Literature DB >> 27171816

Nanoparticles coated with high molecular weight PEG penetrate mucus and provide uniform vaginal and colorectal distribution in vivo.

Katharina Maisel1,2, Mihika Reddy1,2, Qingguo Xu1,3, Sumon Chattopadhyay1,4, Richard Cone1,5, Laura M Ensign1,3,4, Justin Hanes1,2,3,4,6.   

Abstract

AIM: We previously reported that nanoparticles (NPs) coated with 10 kDa PEG were mucoadhesive. Here, we demonstrate that by increasing the surface density, PEG with molecular weight (MW) as high as 40 kDa can be used as a mucoinert NP surface coating. MATERIALS &
METHODS: We compared two sets of reaction conditions for coating model polystyrene NPs with 10 kDa PEG and used optimized conditions to coat NPs with PEG as high as 40 kDa in MW. We then characterized NP transport in human cervicovaginal mucus ex vivo. We further administered PEG-coated NPs to the mouse cervicovaginal tract and colorectum to assess mucosal distribution in vivo. RESULTS &
CONCLUSION: We demonstrate here that PEG with MW as high as 40 kDa can be densely grafted to the surface of NP to prevent interactions with mucus. NP coated with 10-40 kDa PEG rapidly diffused through human cervicovaginal mucus ex vivo, and uniformly lined the mouse colorectal and vaginal epithelium in vivo.

Entities:  

Keywords:  PEG density; PEG molecular weight; hypotonic delivery; mucosal drug delivery; mucus penetrating nanoparticles (MPPs)

Mesh:

Substances:

Year:  2016        PMID: 27171816      PMCID: PMC4897967          DOI: 10.2217/nnm-2016-0047

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  28 in total

Review 1.  Barrier properties of mucus.

Authors:  Richard A Cone
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

Review 2.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

3.  Molecular calculations of poly(ethylene glycol) transport across a swollen poly(acrylic acid)/mucin interface.

Authors:  N A Peppas
Journal:  J Biomater Sci Polym Ed       Date:  1998       Impact factor: 3.517

4.  Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.

Authors:  Jung Soo Suk; Anthony J Kim; Kanika Trehan; Craig S Schneider; Liudmila Cebotaru; Owen M Woodward; Nicholas J Boylan; Michael P Boyle; Samuel K Lai; William B Guggino; Justin Hanes
Journal:  J Control Release       Date:  2014-01-14       Impact factor: 9.776

Review 5.  Nanoparticle PEGylation for imaging and therapy.

Authors:  Jesse V Jokerst; Tatsiana Lobovkina; Richard N Zare; Sanjiv S Gambhir
Journal:  Nanomedicine (Lond)       Date:  2011-06       Impact factor: 5.307

6.  Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter.

Authors:  J J Sahlin; N A Peppas
Journal:  J Biomater Sci Polym Ed       Date:  1997       Impact factor: 3.517

Review 7.  Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces.

Authors:  Y Huang; W Leobandung; A Foss; N A Peppas
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

8.  Nanoparticle diffusion in respiratory mucus from humans without lung disease.

Authors:  Benjamin S Schuster; Jung Soo Suk; Graeme F Woodworth; Justin Hanes
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

Review 9.  Nanoscale technology of mucoadhesive interactions.

Authors:  Nicholas A Peppas; Yanbin Huang
Journal:  Adv Drug Deliv Rev       Date:  2004-09-22       Impact factor: 15.470

10.  Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Authors:  Laura M Ensign; Timothy E Hoen; Katharina Maisel; Richard A Cone; Justin S Hanes
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

View more
  20 in total

1.  Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.

Authors:  Max Kates; Abhijit Date; Takahiro Yoshida; Umara Afzal; Pranjali Kanvinde; Taarika Babu; Nikolai A Sopko; Hotaka Matsui; Noah M Hahn; David J McConkey; Alexander Baras; Justin Hanes; Laura Ensign; Trinity J Bivalacqua
Journal:  Clin Cancer Res       Date:  2017-08-14       Impact factor: 12.531

2.  Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Authors:  Eleni Samaridou; Nikolaos Kalamidas; Irene Santalices; José Crecente-Campo; Maria José Alonso
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

3.  Engineering drug delivery systems to overcome mucosal barriers for immunotherapy and vaccination.

Authors:  Jacob C McCright; Katharina Maisel
Journal:  Tissue Barriers       Date:  2019-11-28

Review 4.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

Review 5.  The particle in the spider's web: transport through biological hydrogels.

Authors:  Jacob Witten; Katharina Ribbeck
Journal:  Nanoscale       Date:  2017-06-22       Impact factor: 7.790

Review 6.  Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

Authors:  Itishri Sahu; A K M Ashiqul Haque; Brian Weidensee; Petra Weinmann; Michael S D Kormann
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

7.  Synthesis of Polyphosphate-Loaded Nanoparticles Using Inverse Miniemulsion Polymerization for Sustained Delivery to the Gastrointestinal Tract.

Authors:  Fernando T P Borges; Georgia Papavasiliou; Fouad Teymour
Journal:  Macromol React Eng       Date:  2019-02-18       Impact factor: 1.931

Review 8.  Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval.

Authors:  Duhyeong Hwang; Jacob D Ramsey; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2020-09-24       Impact factor: 15.470

Review 9.  Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery.

Authors:  Jay M Newby; Ian Seim; Martin Lysy; Yun Ling; Justin Huckaby; Samuel K Lai; M Gregory Forest
Journal:  Adv Drug Deliv Rev       Date:  2017-12-12       Impact factor: 15.470

Review 10.  Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.

Authors:  Hannah C Zierden; Aditya Josyula; Rachel L Shapiro; Henry T Hsueh; Justin Hanes; Laura M Ensign
Journal:  Trends Mol Med       Date:  2021-01-04       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.